Related Experiment Videos
Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Surgery
|August 1, 1975
Summary
Researchers extracted soluble melanoma antigens and tested them using delayed cutaneous hypersensitivity reactions (DCHR) in patients. This study found DCHR is a viable method for evaluating melanoma antigens, paving the way for further research and clinical applications.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Melanoma research requires effective methods for antigen identification and evaluation.
- Soluble tumor antigens are crucial for understanding immune responses in cancer patients.
Purpose of the Study:
- To prepare and evaluate soluble melanoma antigens using delayed cutaneous hypersensitivity reactions (DCHR).
- To assess the diagnostic potential of these antigens in melanoma patients.
Main Methods:
- Soluble melanoma antigens were extracted using 3M KCl.
- Delayed cutaneous hypersensitivity reactions (DCHR) were performed on 52 patients, including melanoma patients and those with other tumors.
- Reactivity was assessed by measuring induration at 24 hours.
Main Results:
- Significant DCHR reactivity (≥10 mm induration) was observed in 20 out of 34 melanoma patients.
- Control groups showed minimal reactivity: three patients reacted to autologous muscle extract, and five out of 18 patients with other tumors reacted to the melanoma antigen.
- Maximum antigen reactivity was observed at the 24-hour time point.
Conclusions:
- Soluble melanoma antigens can be effectively prepared and evaluated using DCHR.
- DCHR demonstrates potential as a method for assessing immune responses to melanoma-associated antigens.
- The availability of these soluble antigens facilitates further purification, characterization, and clinical investigation.